Posts Tagged ‘Pharmaceuticals’

NHS England strikes deals to make new treatments for MS and breast cancer routinely available

NHS England has struck deals to make innovative treatments for Multiple Sclerosis and breast cancer routinely available on the NHS. Patients with Multip...

Pfizer fined record £84.2m for overcharging NHS for anti-epilepsy drug

Drugs giant Pfizer has been fined a record £84.2m by the UK's competition watchdog for overcharging the NHS for an anti-epilepsy drug. The Competition ...

Saatchi’s ‘untested drugs for dying’ bill gets support

A new law that would allow terminally-ill patients in England and Wales to be given untested medicines has received government backing. The Medical Innova...

Pfizer confirms bid interest in UK’s AstraZeneca

US drugs giant Pfizer has confirmed it has contacted AstraZeneca over a possible multi-billion pound takeover. Pfizer said it made an initial approach ...

Novartis and GSK swap assets and launch venture

Novartis and GlaxoSmithKline, two of the world's leading drugmakers, have agreed to exchange assets and combine their consumer healthcare units. Novarti...

GSK to stop paying doctors to speak at events

GlaxoSmithKline (GSK) will stop paying doctors to promote its products through speaking engagements. The pharmaceuticals firm is making major changes to i...

Committee of MPs warns of medicine shortages

Patients in England are suffering from shortages of some medicines, according to the All Party Pharmacy Group of MPs. Their report says part of the prob...

Orphan drug pricing warrants investigation

An open letter from 20 consultants and a patient group calls on the prime minister to take action over a legal loophole that allows drug companies to make ...

Child health threatened by research funding crisis

Research into health conditions affecting babies and older children is facing a funding crisis, say leading doctors, who warn the shortfall is seriously ha...

Trusts criticised over plans to export drugs

NHS hospital trusts have been slammed by the Department of Health over “wholly unacceptable” plans to cash in on the weak pound by exporting medicines ...